A variety of tests are used to capture images inside the body when chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are present.

Regular blood testing for those with CLL and SLL is an important part of managing the disease, as it can provide valuable insights into your overall health.

Tumor lysis syndrome is a rare condition that can happen due to the rapid death of cancer cells.

Autoimmune hemolytic anemia (AIHA) is the most common autoimmune condition associated with CLL and SLL.

Immune thrombocytopenic purpura (ITP) is a rare but serious complication that happens in an estimated 1-5% of those living with CLL and SLL.

Measurable residual disease (MRD) testing measures the amount of cancer cells that are present in blood or bone marrow at the time the sample was collected.

MBL is a condition where there is an accumulation of abnormal B-cells in the blood.

A one page summary of what you need to know about the 3 most important tests that need to be done to guide your CLL treatment.

Fatigue is one of the most common symptoms experienced by those living with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), and it is also commonly overlooked, underreported, and undertreated.